Gilead Sciences, Inc.
333 Lakeside Drive
Foster City
California
94404
U.S.A.
Phone:
800-GILEAD-5 or 650-574-3000
Fax:
650-522-5800
|
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
Key Contacts:
John C. Martin, PhD, Chairman and Chief Executive Officer
John F. Milligan, PhD, President and Chief Operating Officer
Norbert W. Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer
Kevin Young, Executive Vice President, Commercial Operations
Kristen Metza, Senior Vice President, Human Resources
Susan Hubbard, Vice President, Investor Relations
Amy Flood, Senior Director, Public Affairs
Email:
Ownership:
Web Site:
Gilead Sciences, Inc.
Employees:
3,200
Symbol: GILD
|
|
|
Company News |
Gilead Sciences, Inc. (GILD) to Present at the 12th Annual Biotechnology Industry Organization (BIO) CEO Investor Conference on Tuesday, February 9
2/3/2010 10:00:03 AM
More...
|
Per Wold-Olsen Joins Gilead Sciences, Inc. (GILD)'s Board of Directors
1/29/2010 10:39:02 AM
More...
|
Gilead Sciences, Inc. (GILD) Announces Share Repurchase Program
1/29/2010 9:58:55 AM
More...
|
Gilead Sciences, Inc. (GILD) Announces Record Fourth Quarter and Full Year 2009 Financial Results
1/27/2010 9:42:09 AM
More...
|
Gilead Sciences, Inc. (GILD) (JOBS) Profit Beats Street, Shares Up
1/27/2010 7:18:01 AM
More...
|
Gilead Sciences, Inc. (GILD) to Release Fourth Quarter and Year End 2009 Financial Results on Tuesday, January 26, 2010
1/20/2010 10:07:00 AM
More...
|
Phase II Clinical Trial of Gilead Sciences, Inc. (GILD)'s (JOBS) Investigational Integrase-Based, Once-Daily, Fixed-Dose "Quad" Regimen Meets 24-Week Primary Objective
1/6/2010 7:11:48 AM
More...
|
Gilead Sciences, Inc. (GILD) to Present at Two Upcoming Investor Conferences
1/5/2010 9:43:51 AM
More...
|
Gilead Sciences, Inc. (GILD) (JOBS) Heart Drug Disappoints, Program Likely Dropped; Company Says Pivotal Phase of Study Missed Main Goals
12/15/2009 7:10:36 AM
More...
|
Gilead Sciences, Inc. (GILD) (JOBS) Says FDA Advisory Committee Supports Use Of Aztreonam For Inhalation Solution For Patients With Cystic Fibrosis
12/11/2009 7:29:18 AM
More...
|
|
|
|